Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
valproic acid (depakene) (1 trial)
Craniofacial Abnormalities (Phase 2)
Hand Deformities, Congenital (Phase 2)
Osteochondrodysplasias (Phase 2)
Rubinstein-Taybi Syndrome (Phase 2)
Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)